In the first 30 days of starting a GLP-1 medication, most patients begin to notice subtle but meaningful changes in appetite, energy levels, and digestion
Diabetes Technology and CGM Continuous Glucose Monitoring ADA 2026 Broad CGM Mandate CGM is now recommended at diabetes onset for anyone on insulin, on agents that can cause hypoglycemia, or where CGM aids management
Retatrutide reduced liver fat by 82% in trials, compared to roughly 55% for tirzepatide (Nature Medicine, 2024)
Specialty Drugs, 2015 to 2025 Exhibit 88: Change in Commercial Payer Net Drug Spending, Traditional vs
FuturHealth $99-$399 Noom Noom built its reputation on a psychology-based approach to weight management long before GLP-1 medications entered the mainstream